[시장보고서]핵산 분리 및 정제 시장 규모, 점유율과 동향 분석 보고서 : 제품별, 유형별, 용도별, 방법별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

핵산 분리 및 정제 시장 규모, 점유율과 동향 분석 보고서 : 제품별, 유형별, 용도별, 방법별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Method, By End-use, By Region, And Segment Forecasts, 2026 - 2033

상품코드 : 1941776

리서치사 : Grand View Research

발행일 : 2026년 01월

페이지 정보 : 영문 135 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,981,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,491,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,510,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

핵산 분리 및 정제 시장 요약

세계의 핵산 분리 및 정제 시장 규모는 2025년에 60억 5,000만 달러로 평가되며, 2033년까지 128억 4,000만 달러에 달할 것으로 예측됩니다.

2026-2033년 연평균 복합 성장률(CAGR) 10.07%를 나타낼 것으로 예측됩니다. 이러한 확대는 임상 진단에서 시퀀싱 플랫폼의 채택 증가, 유전체학 및 효소학 기반 연구의 성장, R&D 투자 증가 등 여러 요인에 의해 주도되고 있습니다.

또한 분자생물학의 가능성과 정밀의료의 발전은 시장 성장을 더욱 가속화하고 있습니다. 시장 진출기업이 제조 역량 강화를 위한 노력을 강화하고 있는 것도 시장 확대를 촉진하고 있습니다. 지난 수년간 유전성 질환, 암, 감염성 질환의 발생률은 전 세계에서 증가 추세에 있습니다. 지중해빈혈, 겸상적혈구증, 낭포성 섬유증 등의 질환은 개인의 DNA에 있는 유전자 이상에 의해 발생합니다. 핵산 연구는 이러한 질병에 대한 이해를 높이는 데 도움이 됩니다. COVID-19 감염을 감지하기 위한 비용 효율적인 현장 검사 키트와 효율적인 검사 절차의 개발 경쟁은 진단 기술 혁신의 새로운 영역을 촉진했습니다. PCR 워크플로우에서 핵산 분리 및 정제가 중요한 단계이기 때문에 광범위한 상업적 검사 기관에서 SARS-CoV-2 검출을 위한 PCR 채택이 증가하면서 시장을 주도하고 있습니다.

생명공학 산업에서도 진보와 혁신이 눈에 띄게 발전하고 있습니다. 진단 검사는 더 비용 효율적이고 사용하기 쉬워졌습니다. 각 업체들은 DNA 분리 공정의 고도화를 위해 투자하고 있습니다. 또한 자동화된 첨단 장비가 시장에 등장하여 더 빠르고 일관성 있고 깨끗한 프로세스를 실현하고 있습니다. 예를 들어 Thermo Fisher Scientific은 혁신적인 자기 분리 기술을 채택한 자동 핵산 추출 워크스테이션을 제공합니다.

영문목차

Nucleic Acid Isolation & Purification Market Summary

The global nucleic acid isolation and purification market size was valued at USD 6.05 billion in 2025 and is anticipated to reach USD 12.84 billion by 2033, growing at a CAGR of 10.07% from 2026 to 2033. The expansion is fueled by several factors, such as the rise in adoption of sequencing platforms for clinical diagnostics, growth in genomics & enzymology-based research, and an increase in investments in R&D.

In addition, the potential of molecular biology and advancement in precision medicine are further augmenting market growth. Increasing efforts of market participants to strengthen the manufacturing capacity are facilitating market expansion. The incidence of genetic disorders, cancer, and infectious diseases has been growing globally for the past few years. Disorders such as thalassemia, sickle cell anemia, and cystic fibrosis are caused by genetic aberrations in an individual's DNA. Studying nucleic acids helps gain insights into these diseases. The race for developing cost-effective, point-of-contact testing kits and efficient laboratory procedures for detecting COVID-19 infection has driven a new scope of diagnostic innovation. An increase in the adoption of PCR for SARS-CoV-2 detection by a broad range of commercial laboratories drives the market, as nucleic acid isolation & purification is a significant step in the PCR workflow.

The biotechnology industry is also marked by advancements and innovations. Diagnostic tests have become more cost-effective and easier to use. The companies are investing to advance the DNA isolation process. Furthermore, automated and advanced instruments have entered the market with faster, more consistent, and cleaner processes. For instance, Thermo Fisher Scientific offers an Automated Nucleic Acid Extraction Workstation that uses revolutionary magnetic separation technology.

Global Nucleic Acid Isolation And Purification Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nucleic acid isolation and purification market report based on product, type, application, method, end-use, and region.

Product Outlook (Revenue, USD Billion, 2021 - 2033)
Kits & reagents
Instruments
- Manual
- Automatic
Type Outlook (Revenue, USD Billion, 2021 - 2033)
DNA Isolation & Purification
- Genomic DNA isolation & purification
- Plasmid DNA isolation & purification
- Viral DNA isolation & purification
- Other
RNA Isolation & Purification
- miRNA isolation & purification
- mRNA isolation & purification
- Total RNA isolation & purification
- Other
Application Outlook (Revenue, USD Billion, 2021 - 2033)
Precision medicine
Diagnostics
Drug discovery & development
Agriculture and animal research
Other applications
Method Outlook (Revenue, USD Billion, 2021 - 2033)
Column based
Magnetic beads
Reagent based
Others
End-use Outlook (Revenue, USD Billion, 2021 - 2033)
Academic research institutes
Pharmaceutical & biotechnology companies
Contract research organizations
Hospitals and diagnostic centers
Other end-use
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Type
- 1.2.3. Application
- 1.2.4. Method
- 1.2.5. End use
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Nucleic Acid Isolation And Purification Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing incidence of cancer, genetic disorders, and infectious diseases
  - 3.2.1.2. Increase in public-private funding for biotechnology and life science research
  - 3.2.1.3. Advancements in automation
  - 3.2.1.4. Growth in NGS technologies
  - 3.2.1.5. Growing demand for genetically modified crops and organisms
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Expensive instruments and consequent low penetration in emerging countries
  - 3.2.2.2. Challenges related to the use of big data and bioinformatics
3.3. Industry Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

4.1. Segment Dashboard
4.2. Nucleic Acid Isolation and Purification Market: Product Movement Analysis
4.3. Kits & Reagents
- 4.3.1. Kits & reagents market estimates and forecasts 2021 - 2033 (USD Million)
4.4. Instruments
- 4.4.1. Instruments market estimates and forecasts 2021 - 2033 (USD Million)
- 4.4.2. Manual
  - 4.4.2.1. Manual market estimates and forecasts 2021 - 2033 (USD Million)
- 4.4.3. Automatic
  - 4.4.3.1. Automatic market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 5. Type Business Analysis

5.1. Segment Dashboard
5.2. Nucleic Acid Isolation and Purification Market: Type Movement Analysis
5.3. DNA Isolation & Purification
- 5.3.1. DNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
- 5.3.2. Genomic DNA Isolation & Purification
  - 5.3.2.1. Genomic DNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
- 5.3.3. Plasmid DNA Isolation & Purification
  - 5.3.3.1. Plasmid DNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
- 5.3.4. Viral DNA Isolation & Purification
  - 5.3.4.1. Viral DNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
- 5.3.5. Other
  - 5.3.5.1. Other market estimates and forecasts 2021 - 2033 (USD Million)
5.4. RNA Isolation & Purification
- 5.4.1. RNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
- 5.4.2. miRNA Isolation & Purification
  - 5.4.2.1. miRNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
- 5.4.3. mRNA Isolation & Purification
  - 5.4.3.1. mRNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
- 5.4.4. Total RNA Isolation & Purification
  - 5.4.4.1. Total RNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
- 5.4.5. Other
  - 5.4.5.1. Other market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

6.1. Segment Dashboard
6.2. Nucleic Acid Isolation and Purification Market: Application Movement Analysis
6.3. Precision Medicine
- 6.3.1. Precision medicine market estimates and forecasts 2021 - 2033 (USD Million)
6.4. Diagnostics
- 6.4.1. Diagnostics market estimates and forecasts 2021 - 2033 (USD Million)
6.5. Drug Discovery & Development
- 6.5.1. Drug discovery & development market estimates and forecasts 2021 - 2033 (USD Million)
6.6. Agriculture and Animal Research
- 6.6.1. Agriculture and animal research market estimates and forecasts 2021 - 2033 (USD Million)
6.7. Other Applications
- 6.7.1. Other applications market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 7. Method Business Analysis

7.1. Segment Dashboard
7.2. Nucleic Acid Isolation and Purification Market: Method Movement Analysis
7.3. Column Based
- 7.3.1. Column based medicine market estimates and forecasts 2021 - 2033 (USD Million)
7.4. Magnetic Beads
- 7.4.1. Magnetic beads market estimates and forecasts 2021 - 2033 (USD Million)
7.5. Reagent Based
- 7.5.1. Reagent based market estimates and forecasts 2021 - 2033 (USD Million)
7.6. Others
- 7.6.1. Others market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 8. End Use Business Analysis

8.1. Segment Dashboard
8.2. Nucleic Acid Isolation and Purification Market: End Use Movement Analysis
8.3. Academic Research Institutes
- 8.3.1. Academic research institutes market estimates and forecasts 2021 - 2033 (USD million)
8.4. Pharmaceutical and Biotechnology Companies
- 8.4.1. Pharmaceutical and biotechnology companies market estimates and forecasts 2021 - 2033 (USD Million)
8.5. Contract Research Organizations
- 8.5.1. Contract research organizations market estimates and forecasts 2021 - 2033 (USD Million)
8.6. Hospitals and Diagnostic Centers
- 8.6.1. Hospitals and diagnostic centers market estimates and forecasts 2021 - 2033 (USD Million)
8.7. Other End-use
- 8.7.1. Other end-use market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 9. Regional Business Analysis

9.1. Regional Market Share Analysis, 2025 & 2033
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.4. North America
- 9.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 9.4.2. U.S.
  - 9.4.2.1. Key country dynamics
  - 9.4.2.2. Competitive scenario
  - 9.4.2.3. Regulatory framework
  - 9.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 9.4.3. Canada
  - 9.4.3.1. Key country dynamics
  - 9.4.3.2. Competitive scenario
  - 9.4.3.3. Regulatory framework
  - 9.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 9.4.4. Mexico
  - 9.4.4.1. Key country dynamics
  - 9.4.4.2. Competitive scenario
  - 9.4.4.3. Regulatory framework
  - 9.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
9.5. Europe
- 9.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.2. UK
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Competitive scenario
  - 9.5.2.3. Regulatory framework
  - 9.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.3. Germany
  - 9.5.3.1. Key country dynamics
  - 9.5.3.2. Competitive scenario
  - 9.5.3.3. Regulatory framework
  - 9.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.4. France
  - 9.5.4.1. Key country dynamics
  - 9.5.4.2. Competitive scenario
  - 9.5.4.3. Regulatory framework
  - 9.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.5. Italy
  - 9.5.5.1. Key country dynamics
  - 9.5.5.2. Competitive scenario
  - 9.5.5.3. Regulatory framework
  - 9.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.6. Spain
  - 9.5.6.1. Key country dynamics
  - 9.5.6.2. Competitive scenario
  - 9.5.6.3. Regulatory framework
  - 9.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.7. Norway
  - 9.5.7.1. Key country dynamics
  - 9.5.7.2. Competitive scenario
  - 9.5.7.3. Regulatory framework
  - 9.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.8. Sweden
  - 9.5.8.1. Key country dynamics
  - 9.5.8.2. Competitive scenario
  - 9.5.8.3. Regulatory framework
  - 9.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.9. Denmark
  - 9.5.9.1. Key country dynamics
  - 9.5.9.2. Competitive scenario
  - 9.5.9.3. Regulatory framework
  - 9.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
9.6. Asia Pacific
- 9.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.2. Japan
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. Competitive scenario
  - 9.6.2.3. Regulatory framework
  - 9.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.3. China
  - 9.6.3.1. Key country dynamics
  - 9.6.3.2. Competitive scenario
  - 9.6.3.3. Regulatory framework
  - 9.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.4. India
  - 9.6.4.1. Key country dynamics
  - 9.6.4.2. Competitive scenario
  - 9.6.4.3. Regulatory framework
  - 9.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.5. Australia
  - 9.6.5.1. Key country dynamics
  - 9.6.5.2. Competitive scenario
  - 9.6.5.3. Regulatory framework
  - 9.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.6. South Korea
  - 9.6.6.1. Key country dynamics
  - 9.6.6.2. Competitive scenario
  - 9.6.6.3. Regulatory framework
  - 9.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.7. Thailand
  - 9.6.7.1. Key country dynamics
  - 9.6.7.2. Competitive scenario
  - 9.6.7.3. Regulatory framework
  - 9.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
9.7. Latin America
- 9.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 9.7.2. Brazil
  - 9.7.2.1. Key country dynamics
  - 9.7.2.2. Competitive scenario
  - 9.7.2.3. Regulatory framework
  - 9.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 9.7.3. Argentina
  - 9.7.3.1. Key country dynamics
  - 9.7.3.2. Competitive scenario
  - 9.7.3.3. Regulatory framework
  - 9.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
9.8. MEA
- 9.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 9.8.2. South Africa
  - 9.8.2.1. Key country dynamics
  - 9.8.2.2. Competitive scenario
  - 9.8.2.3. Regulatory framework
  - 9.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 9.8.3. Saudi Arabia
  - 9.8.3.1. Key country dynamics
  - 9.8.3.2. Competitive scenario
  - 9.8.3.3. Regulatory framework
  - 9.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 9.8.4. UAE
  - 9.8.4.1. Key country dynamics
  - 9.8.4.2. Competitive scenario
  - 9.8.4.3. Regulatory framework
  - 9.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 9.8.5. Kuwait
  - 9.8.5.1. Key country dynamics
  - 9.8.5.2. Competitive scenario
  - 9.8.5.3. Regulatory framework
  - 9.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2025
10.4. Company Profiles/Listing
- 10.4.1. QIAGEN
  - 10.4.1.1. Company overview
  - 10.4.1.2. Financial performance
  - 10.4.1.3. Product benchmarking
  - 10.4.1.4. Strategic initiatives
- 10.4.2. Thermo Fisher Scientific, Inc.
  - 10.4.2.1. Company overview
  - 10.4.2.2. Financial performance
  - 10.4.2.3. Product benchmarking
  - 10.4.2.4. Strategic initiatives
- 10.4.3. Illumina, Inc.
  - 10.4.3.1. Company overview
  - 10.4.3.2. Financial performance
  - 10.4.3.3. Product benchmarking
  - 10.4.3.4. Strategic initiatives
- 10.4.4. Danaher
  - 10.4.4.1. Company overview
  - 10.4.4.2. Financial performance
  - 10.4.4.3. Product benchmarking
  - 10.4.4.4. Strategic initiatives
- 10.4.5. F. Hoffmann-La Roche Ltd
  - 10.4.5.1. Company overview
  - 10.4.5.2. Financial performance
  - 10.4.5.3. Product benchmarking
  - 10.4.5.4. Strategic initiatives
- 10.4.6. Merck KGaA
  - 10.4.6.1. Company overview
  - 10.4.6.2. Financial performance
  - 10.4.6.3. Product benchmarking
  - 10.4.6.4. Strategic initiatives
- 10.4.7. Agilent Technologies
  - 10.4.7.1. Company overview
  - 10.4.7.2. Financial performance
  - 10.4.7.3. Product benchmarking
  - 10.4.7.4. Strategic initiatives
- 10.4.8. Bio-Rad Laboratories, Inc.
  - 10.4.8.1. Company overview
  - 10.4.8.2. Financial performance
  - 10.4.8.3. Product benchmarking
  - 10.4.8.4. Strategic initiatives
- 10.4.9. Takara Bio Inc.
  - 10.4.9.1. Company overview
  - 10.4.9.2. Financial performance
  - 10.4.9.3. Product benchmarking
  - 10.4.9.4. Strategic initiatives
- 10.4.10. Promega Corporation
  - 10.4.10.1. Company overview
  - 10.4.10.2. Financial performance
  - 10.4.10.3. Product benchmarking
  - 10.4.10.4. Strategic initiatives

한글목차

핵산 분리 및 정제 시장 요약

목차

제1장 조사 방법과 범위

제2장 개요

제3장 핵산 분리 및 정제에 관한 시장 변수, 동향 및 범위

제4장 제품별 비즈니스 분석

제5장 유형별 비즈니스 분석

제6장 용도별 비즈니스 분석

제7장 방법별 비즈니스 분석

제8장 최종 용도별 비즈니스 분석

제9장 지역별 비즈니스 분석

제10장 경쟁 구도